Algorae Pharmaceuticals Ltd (1AI) — Capital Reinvestment Ratio

Latest as of September 2013: 0.01x

Algorae Pharmaceuticals Ltd (1AI) has a Capital Reinvestment Ratio of 0.01x as of September 2013, meaning it reinvests 0% of its operating cash flow (AU$334.25K) in capital expenditures (AU$5.00K). Check Algorae Pharmaceuticals Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

AU$334.25K

AUD

Capital Expenditures

AU$5.00K

AUD

Data as of

Sep 2013

Most recent filing

Algorae Pharmaceuticals Ltd Capital Reinvestment Ratio (2013–2013)

This chart tracks Algorae Pharmaceuticals Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Algorae Pharmaceuticals Ltd cash conversion from operations.

Annual Capital Reinvestment Ratio for Algorae Pharmaceuticals Ltd (2013–2013)

Year-by-year Capital Reinvestment Ratio for Algorae Pharmaceuticals Ltd from 2013 to 2013. See Algorae Pharmaceuticals Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2013	0.01x	AU$1.34 Million	AU$20.00K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow